Trial · NCT00314132
Results by group80
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 80
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Fatigue | 90 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Fatigue | 365 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Malaise | 69 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Malaise | 297 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Injection Site Pain | 36 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Injection Site Pain | 199 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Feeling Hot | 27 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Feeling Hot | 152 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Chills | 17 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Chills | 112 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Injection Site Erythema | 14 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Injection Site Erythema | 74 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Injection Site Pruritus | 11 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Injection Site Pruritus | 64 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Headache | 99 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Headache | 417 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Myalgia | 48 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Myalgia | 265 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | Placebo | Arthralgia | 21 | Participants | |
| Number of Participants Reporting Treatment Related Adverse Events Post Vaccination With Either ChimeriVax™-JE or a Placebo | ChimeriVax™-JE 4 log10 PFU Vaccine | Arthralgia | 119 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00314132/results